According to IMARC Group latest report titled “Parenteral Nutrition Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, offers a comprehensive analysis of the industry, which comprises insights on parenteral nutrition market share. The report also includes competitor and regional analysis, and contemporary advancements in the global market. The global parenteral nutrition market size reached US$ 6.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 9.9 Billion by 2028, exhibiting a growth rate (CAGR) of 6.7% during 2023-2028.
Parenteral nutrition refers to the administration of essential nutrients directly into the bloodstream through intravenous infusion. It is a specialized form of nutrition support used when a person is unable to consume or absorb adequate nutrition through the gastrointestinal trac. It is also prescribed for individuals who have conditions such as intestinal failure, short bowel syndrome, and severe malabsorption. Parenteral nutrition solutions are formulated by healthcare professionals, including dietitians and pharmacists, considering the patient’s age, weight, medical condition, and specific nutritional requirements. It involves the administration of nutritionally balanced solutions directly into the bloodstream, bypassing the digestive system. This method ensures that patients receive the necessary nutrients, including carbohydrates, proteins, lipids, electrolytes, vitamins, and minerals, to meet their dietary requirements.
Get a Sample Copy of this Report: https://www.imarcgroup.com/parenteral-nutrition-market/requestsample
Market Trends:
The rising incidence of chronic diseases among the masses is driving the global market. Furthermore, the adoption of parenteral nutrition in critical care units and intensive care settings is growing rapidly, thereby contributing to the demand. Besides, parenteral nutrition offers a reliable means of delivering nutrients directly into the bloodstream, helping to maintain the patient’s metabolic and immune functions. This is creating a positive market outlook. Moroever, several leading players are developing advanced formulations and delivery systems that enhance safety, convenience, and efficacy, thus providing a boost to the market. Additionally, numerous major companies are also focusing on developing parenteral nutrition solutions with reduced plastic waste, recyclable packaging, and lower energy consumption during production, which is acting as another growth inducing factor. Besides, the increasing environmental consciousness and regulatory scrutiny are impacting the market favorably.
View Full Report with TOC & List of Figure: https://www.imarcgroup.com/parenteral-nutrition-market
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
- Aculife Healthcare Private Limited
- Braun Melsungen AG
- Baxter International Inc.
- Fresenius SE & Co. KGaA
- Grifols S.A.
- Otsuka Pharmaceutical Factory Inc.
- Pfizer Inc.
- Servona GmbH
Parenteral Nutrition Market Segmentation:
Our report has categorized the market based on region, nutrient type and end use.
Breakup by Nutrient Type:
- Carbohydrates
- Lipid Emulsion
- Single Dose Amino Acid Solution
- Trace Elements
- Vitamins and Minerals
Breakup by End User:
- Hospitals
- Clinics
- Others
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key highlights of the report:
- Market Performance (2017-2022)
- Market Outlook (2023-2028)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe:- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
